Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual Covalent Inhibition of PKM and IMPDH Targets Metabolism in Cutaneous Metastatic Melanoma
Marwa Zerhouni, Anthony R. Martin, Nathan Furstoss, et al.
Cancer Research (2021) Vol. 81, Iss. 14, pp. 3806-3821
Open Access | Times Cited: 12

Showing 12 citing articles:

Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment
Shilin Wang, Guohong Liu, Yirong Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 87
Tumor-associated macrophages: new insights on their metabolic regulation and their influence in cancer immunotherapy
Li Xiao, Qiao Wang, Hongling Peng
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Canagliflozin reduces chemoresistance in hepatocellular carcinoma through PKM2-c-Myc complex-mediated glutamine starvation
Yuan Zeng, Haoran Jiang, Xiangting Zhang, et al.
Free Radical Biology and Medicine (2023) Vol. 208, pp. 571-586
Closed Access | Times Cited: 19
Bioinformatics Analysis of Purine Metabolism Key Genes in Gastric Cancer Chemotherapy Resistance and Prognosis
运 邵
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 1023-1034
Closed Access
Compartmentalization and regulation of GTP in control of cellular phenotypes
David W. Wolff, Anna Bianchi, Mikhail A. Nikiforov
Trends in Molecular Medicine (2022) Vol. 28, Iss. 9, pp. 758-769
Open Access | Times Cited: 13
Advances in Understanding Drug Resistance Mechanisms and Innovative Clinical Treatments for Melanoma
Xiaoya He, Hao Deng, Wei Liu, et al.
Current Treatment Options in Oncology (2024)
Closed Access | Times Cited: 1
Thymidine Kinase 1 Drives Skin Cutaneous Melanoma Malignant Progression and Metabolic Reprogramming
Sipeng Zuo, Huixue Wang, Lin Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Connections between metabolism and epigenetic modifications in cancer
Guangchao Wang, Jing‐Dong J. Han
Medical Review (2021) Vol. 1, Iss. 2, pp. 199-221
Open Access | Times Cited: 9
TP53 mutation‐related senescence is an indicator of hepatocellular carcinoma patient outcomes from multiomics profiles
Yu‐Yan Chen, Zhengyi Zhu, Tao Ma, et al.
Smart Medicine (2023) Vol. 2, Iss. 2
Open Access | Times Cited: 2
Dual targeting of GPX4 and TXNRD1 triggers eradication of AML cells through induction of apoptosis and ferroptosis
Cécile Favreau, Coline Savy, Maxence Bourgoin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Covalent drugs based on small molecules and peptides for disease theranostics
Yingjin Zhang, Jian‐Xiao Liang, Yinsheng Xu, et al.
Biomaterials Science (2023) Vol. 12, Iss. 3, pp. 564-580
Closed Access | Times Cited: 1
Protein profiling reveals potential isomiR-associated cross-talks among RNAs in cholangiocarcinoma
Li Guo, Yuyang Dou, Yifei Yang, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 5722-5734
Open Access | Times Cited: 3
Page 1

Scroll to top